应用68Ga-PSMA-11 PET/CT在体内证实膀胱腺癌PSMA表达
基于近期免疫组化研究提示膀胱腺癌存在PSMA表达,作者假设该表达可在体内用68Ga-PSMA-11 PET/CT证实,本例结果与假设一致。
要点
- 膀胱腺癌患者行68Ga-PSMA-11 PET/CT可见原发肿瘤PSMA表达。
- 转移淋巴结亦显示PSMA表达。
核心结论
- 膀胱腺癌的原发肿瘤及转移淋巴结在体内可显示PSMA表达,与作者基于免疫组化研究提出的假设一致。
研究设计与样本
- 本文为病例报告,报告一名膀胱外翻男性膀胱腺癌患者,因分期行PET/CT检查。
主要发现
- 68Ga-PSMA-11 PET/CT显示原发肿瘤及转移淋巴结均有PSMA表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In vitro and in vivo studies have demonstrated prostate-specific membrane antigen (PSMA) expression in various malignant and benign tumors. Based on the recent immunohistochemical study showing PSMA expression in adenocarcinoma of urinary bladder, we hypothesized that PSMA expression in adenocarcinoma of urinary bladder can be demonstrated in vivo using Ga-PSMA 11 PET/CT. We present a man with exstrophy bladder, presenting with adenocarcinoma urinary bladder referred for staging PET/CT. Both F-FDG and Ga-PSMA-11 PET/CT were done, which showed PSMA expression in the primary tumor as well as metastatic lymph nodes.
引用
- Roy SG, Parida GK, Tripathy S, et al. In Vivo Demonstration of PSMA Expression in Adenocarcinoma Urinary Bladder Using 68Ga-PSMA 11 PET/CT. Clin Nucl Med. 2017. PMID: 28481793. doi:10.1097/RLU.0000000000001683
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。